Agenus Balance Sheet Health
Financial Health criteria checks 0/6
Agenus has a total shareholder equity of $-148.4M and total debt of $12.9M, which brings its debt-to-equity ratio to -8.7%. Its total assets and total liabilities are $313.9M and $462.3M respectively.
Key information
-8.7%
Debt to equity ratio
US$12.91m
Debt
| Interest coverage ratio | n/a |
| Cash | US$76.11m |
| Equity | -US$148.38m |
| Total liabilities | US$462.30m |
| Total assets | US$313.91m |
Recent financial health updates
Recent updates
Benign Growth For Agenus Inc. (NASDAQ:AGEN) Underpins Stock's 25% Plummet
Mar 29
Agenus: 2024 May Finally Be The Year For A Major Turnaround
Jan 18Improved Revenues Required Before Agenus Inc. (NASDAQ:AGEN) Shares Find Their Feet
Dec 22News Flash: Analysts Just Made A Huge Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Forecasts
Nov 09A Look At The Fair Value Of Agenus Inc. (NASDAQ:AGEN)
Oct 04Industry Analysts Just Made A Notable Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Revenue Forecasts
May 10VBI Vaccines, Agenus to examine VBI-1901 + balstilimab combo for glioblastoma
Oct 12Agenus New Trials Set It Up For The Long Haul
Sep 27Agenus: It's Always Tomorrow
Sep 16Agenus GAAP EPS of -$0.17, revenue of $20.93M
Aug 09Agenus: Successfully Pulled Itself Away From Disaster
Jul 04Agenus: Not Quite Enough
Apr 19Auditors Have Doubts About Agenus (NASDAQ:AGEN)
Mar 06Agenus: Making Another Effort With The FDA
Jan 25Agenus Inc.'s Imminent 1181/Bal Data Release And MiNK IPO Should Lead To Enormous Valuation Gains
Aug 25Agenus Multiple Value-Adding Events Ahead
Aug 18Party Time: Brokers Just Made Major Increases To Their Agenus Inc. (NASDAQ:AGEN) Earnings Forecasts
Aug 11FDA accepts Agenus' balstilimab BLA under "priority review" status
Jun 17Agenus/Bristol-Myers Squibb Deal Makes For A Strong Buy
May 26Agenus shares fall after Q1 topline miss
May 06Is Agenus Inc. (NASDAQ:AGEN) Popular Amongst Institutions?
Feb 15Financial Position Analysis
Short Term Liabilities: AGEN has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: AGEN has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: AGEN has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: AGEN's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AGEN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if AGEN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.